Literature DB >> 8448565

Therapy with 125I-labelled internalized and non-internalized monoclonal antibodies in nude mice with human colon carcinoma xenografts.

E F Aronsson1, J Grétarsdóttir, L Jacobsson, T Bäck, S Hertzman, S Lindegren, B Karlsson, L Lindholm, S Holmberg, L Hafström.   

Abstract

The therapeutic effects of 125I-labelled (18-97 MBq) monoclonal antibodies (MAb) C-242, C-215 and S-S.1 were studied in nude mice with human colorectal adenocarcinoma tumours. The antibodies were administered 2 or 10-16 days after implantation of the tumour cells. The monoclonal antibody C-242 was internalized into the tumour cells, C-215 was internalized to a lower degree while S-S.1 (unspecific MAb) was not internalized at all. No enhanced therapeutic effect of 125I-C-242 was observed, as a result of Auger electrons, compared with 125I-C-215 and 125I-S-S.1.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8448565     DOI: 10.1016/0969-8051(93)90105-4

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  3 in total

1.  Radiolabeled cyclosaligenyl monophosphates of 5-iodo-2'-deoxyuridine, 5-iodo-3'-fluoro-2',3'-dideoxyuridine, and 3'-fluorothymidine for molecular radiotherapy of cancer: synthesis and biological evaluation.

Authors:  Zbigniew P Kortylewicz; Yu Kimura; Kotaro Inoue; Elizabeth Mack; Janina Baranowska-Kortylewicz
Journal:  J Med Chem       Date:  2012-03-08       Impact factor: 7.446

2.  Biodistribution and dosimetry of free 211At, 125I- and 131I- in rats.

Authors:  Johan Spetz; Nils Rudqvist; Eva Forssell-Aronsson
Journal:  Cancer Biother Radiopharm       Date:  2013-06-22       Impact factor: 3.099

3.  Meitner-Auger Electron Emitters for Targeted Radionuclide Therapy: Mercury-197m/g and Antimony-119

Authors:  Parmissa Randhawa; Aeli P Olson; Shaohuang Chen; Kaley Lexi Gower-Fry; Cornelia Hoehr; Jonathan W Engle; Caterina F Ramogida; Valery Radchenko
Journal:  Curr Radiopharm       Date:  2021
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.